Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients
Publication date
2017-01
Authors
Nijenhuis, C M
Huitema, A D R
Blank, C
Haanen, J B A G
van Thienen, J V
Rosing, H
Schellens, Johannes
Beijnen, Jos
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
vemurafenib, pharmacokinetics, therapeutic drug monitoring, routine clinical care, exposure-response, LC-MS/MS, Taverne
Citation
Nijenhuis, C M, Huitema, A D R, Blank, C, Haanen, J B A G, van Thienen, J V, Rosing, H, Schellens, J H M & Beijnen, J H 2017, 'Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients', Journal of Clinical Pharmacology, vol. 57, no. 1, pp. 125-128. https://doi.org/10.1002/jcph.788